Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study.
da Silva JL, de Souza BSW, de Albuquerque LZ, Aleixo SB, Resende GADS, de Oliveira DGB, Dos Santos EN, Nogueira-Rodrigues A, Clara RO, Gaui MFD, Mota ACA, de Lima VCC, Rosa DD, Munhoz RR, Morbeck IAP, Gelatti ACZ, Mathias CMC, de Melo AC. da Silva JL, et al. Among authors: rosa dd. PLoS One. 2023 Dec 21;18(12):e0295597. doi: 10.1371/journal.pone.0295597. eCollection 2023. PLoS One. 2023. PMID: 38127882 Free PMC article.
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.
Oliveira LJC, Megid TBC, Rosa DD, Magliano CADS, Assad DX, Argolo DF, Sanches SM, Testa L, Bines J, Kaliks R, Caleffi M, de Melo Gagliato D, Sahade M, Barroso-Sousa R, Corrêa TS, Shimada AK, Batista DN, Musse Gomes D, Cesca MG, Gaudêncio D, Moura LMA, de Araújo JAP, Katz A, Mano MS. Oliveira LJC, et al. Among authors: rosa dd. Ther Adv Med Oncol. 2022 Dec 26;14:17588359221141760. doi: 10.1177/17588359221141760. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36601632 Free PMC article.
Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2- advanced breast cancer: a Brazilian public health care system perspective.
Rosa DD, Magliano CADS, Simon SD, Amorim G, Reinert T, Landeiro L, Gagliato DM, Exman P, Argolo D, Guilgen G, Mano M, Testa L, Liedke P, Barroso R, Sasse M, Buehler AM. Rosa DD, et al. Ther Adv Med Oncol. 2022 Jun 20;14:17588359221100865. doi: 10.1177/17588359221100865. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36339925 Free PMC article.
An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management.
Oliveira CA, Mercês ÉAB, Portela FS, Malheiro LFL, Silva HBL, De Benedictis LM, De Benedictis JM, Silva CCDE, Santos ACL, Rosa DP, Velozo HS, de Jesus Soares T, de Brito Amaral LS. Oliveira CA, et al. Clin Exp Nephrol. 2024 Apr 27. doi: 10.1007/s10157-024-02490-x. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38678166 Review.
Breast and gynecologic cancers as a Brazilian health priority.
Nogueira-Rodrigues A, Rosa DD, Suzuki DA, Paulino E, Landeiro LCG, Scaranti M, Madi MR, Hoff PM. Nogueira-Rodrigues A, et al. Among authors: rosa dd. Rev Assoc Med Bras (1992). 2023 Aug 4;69(suppl 1):e2023S120. doi: 10.1590/1806-9282.2023S120. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37556639 Free PMC article. Review.
Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115).
Maschmann RM, De Jesus RG, Werutsky G, Rebelatto TF, Queiroz G, Simon SD, Bines J, Barrios CHE, Rosa DD. Maschmann RM, et al. Among authors: rosa dd. Breast Cancer Res Treat. 2023 Feb;198(1):123-130. doi: 10.1007/s10549-022-06809-8. Epub 2022 Dec 31. Breast Cancer Res Treat. 2023. PMID: 36586038
117 results